U.K. Hereditary Testing Market, 2026-2033

Name: U.K. Hereditary Testing Market
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The hereditary testing market in U.K. is expected to reach a projected revenue of USD 1,821.6 million by 2033. A compound annual growth rate of 16.1% is expected of the UK hereditary testing market from 2026 to 2033.

Clinical Diagnostics
- Genetic Testing
  - hereditary testing market

UK hereditary testing disease type outlook (Revenue, USD million, 2021-2033)
- Hereditary Cancer Testing
  - Lung Cancer
  - Breast Cancer
  - Colorectal Cancer
  - Cervical Cancer
  - Ovarian Cancer
  - Prostate Cancer
  - Stomach/Gastric Cancer
  - Melanoma
  - Sarcoma
  - Uterine Cancer
  - Pancreatic Cancer
  - Others
- Hereditary Non-cancer Testing
  - Genetic Tests
    - Cardiac Diseases
    - Rare Diseases
    - Other Diseases
  - Preimplantation Genetic Diagnosis & Screening
  - Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
  - Newborn Genetic Screening
UK hereditary testing technology outlook (Revenue, USD million, 2021-2033)
- Cytogenetic
- Biochemical
- Molecular Testing

U.K. Hereditary Testing Market, 2026-2033

Data Tree